Log in to save to my catalogue

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in...

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1837321751

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China

About this item

Full title

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China

Publisher

New Delhi: Springer India

Journal title

Hepatology international, 2016-11, Vol.10 (6), p.924-936

Language

English

Formats

Publication information

Publisher

New Delhi: Springer India

More information

Scope and Contents

Contents

Background
Tenofovir disoproxil fumarate (TDF) is newly available for treatment of chronic hepatitis B patients in China. To date, no study has been conducted to examine the cost-effectiveness of this treatment. The aim of this study was to estimate the cost-effectiveness of TDF versus four oral nucleos(t)ide analogs [lamivudine (LAM), adefovir...

Alternative Titles

Full title

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1837321751

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1837321751

Other Identifiers

ISSN

1936-0533

E-ISSN

1936-0541

DOI

10.1007/s12072-016-9741-6

How to access this item